Ads
related to: bristol-myers squibb
Search results
Why Is Bristol Myers Squibb Stock Trading Lower On Thursday? - Bristol-Myers Squibb (NYSE:BMY)
Benzinga· 14 hours agoThursday, Bristol Myers Squibb & Co BMY posted first-quarter revenues of $11.9 billion, beating the...
Beyond the Balance Sheet: What SWOT Reveals About Bristol-Myers Squibb Co (BMY)
GuruFocus.com via Yahoo Finance· 49 minutes agoComprehensive SWOT analysis based on the latest SEC 10-Q filing. Insight into Bristol-Myers Squibb's...
Why Bristol Myers Squibb Stock Is Sinking Today
Motley Fool via Yahoo Finance· 14 hours agoShares of Bristol Myers Squibb (NYSE: BMY) were down 8.3% as of 11:19 a.m. ET on Thursday. The sell-off came after the big drugmaker announced its...
Is Bristol Myers Squibb Stock a Millionaire Maker?
Motley Fool via Yahoo Finance· 15 hours agoMany top healthcare stocks provide investors with long-term stability, promising growth prospects, and in some cases even a dividend. Yet, investors...
Bristol-Myers Squibb Layoffs 2024: What to Know About the Latest BMY Job Cuts
InvestorPlace· 14 hours agoBristol-Myers Squibb (NYSE:BMY) layoffs are a hot topic on Thursday after the biopharmaceutical...
Bristol-Myers Q1 Loss Narrower Than Expected, Sales Beat - ADMA Biologics (NASDAQ:ADMA), ANI...
Benzinga· 4 hours agoBristol-Myers Squibb Company BMY reported an adjusted loss per share of $4.40, narrower than the...
Q1 2024 Bristol-Myers Squibb Co Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 3 hours agoParticipants Adam Lenkowsky; Executive VP, Chief Commercialization Officer & Head of U.S. Oncology; Bristol-Myers Squibb Company Christopher S. Boerner; CEO & Chairman; Bristol-Myers Squibb ...
Merck and Bristol-Myers Squibb are bracing to lose their most lucrative patents this decade
Quartz· 10 hours agoPharma giants Merck and Bristol-Myers Squibb are both getting ready for some of their key drug...
Analyst Report: Bristol-Myers Squibb Company
Morningstar Research via Yahoo Finance· 12 hours agoBristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where ...
Reviva Pharmaceuticals (NASDAQ:RVPH) vs. Bristol-Myers Squibb (NYSE:BMY) Head to Head Survey
ETF DAILY NEWS· 1 day agoBristol-Myers Squibb (NYSE:BMY – Get Free Report) and Reviva Pharmaceuticals (NASDAQ:RVPH – Get Free Report) are both medical companies, but which is the better investment? We will compare the ...